Sunstone Therapies Products Competitors Financials ❤️ SunStone Crunchbase Company Profile Funding

Top Sunstone Development Competitors and Alternatives Craft

Sunstone Life Science Ventures European venture capital

Sunstone Therapies Announces Publication of Positive Data

SunStone Crunchbase Company Profile Funding

Sunstone Therapies Products Competitors Financials

Sunstone Properties Trust LLC Company Profile and News

Sunstone Therapies Celebrates Three Year Anniversary With

Sunstone Life Science Ventures Crunchbase Investor Profile

EduVersity 734 Competitors and Alternatives Tracxn

Sunstone Therapies Company Profile

Sunstone Development Co Ltd Company Profile and News

Financials of Sunstone Learning Private Limited Tofler

Top Sunstone Alternatives Competitors CB Insights


Come and check all categories at a surprisingly low price, you'd never want to miss it. Only today, enjoy all categories up to 90% off your purchase. Hurry & shop mow. Learn without limits with unlimited access to 1M+ titles across 1,000+ Topics. Quality reading with Online Subscription. Stop Overspending on Textbooks. Sunstone Life Science Ventures is a venture capital investment firm that focuses on developing and expanding early-stage life science companies with strong potential to achieve global success in their markets. Use the CB Insights Platform to explore Sunstone Life Science Ventures's full profile. Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations. Sunstone Capital is an early-stage life science and technology venture capital company invests in european start-up companies Sunstone Life Science’s primary competitors include Northcap, Northzone, SEED Capital and 9 more. Here is a list of all 20 approved products developed by Sunstone funded life science companies: Zealand Pharma A/S. Lyxumia® (lixisenatide): A GLP-1 receptor agonist developed by Zealand Pharma and marketed by Sanofi; Zegalogue® (dasiglucagon): A glucagon receptor agonist for the treatment of severe hypoglycemia in people with diabetes. Maximize productivity, consistency and reliability across the entire cell therapy workflow. Connect to our portfolio of innovative, scalable, and flexible products for cell therapy. 1 déc. 2024 · 01 Dec, 2024, 09:00 ET ROCKVILLE, Md., Dec. 1, 2024 /PRNewswire/ -- Sunstone Therapies, a company dedicated to easing the suffering associated with cancer, today formalizes its structure to. We exist to accelerate on-the-ground learning and operations necessary to approve and scale psychedelic therapies in the medical setting. What we offer Trials and Research. 6 nov. 2024 · Rockville, Maryland, November 06, 2024 – Sunstone Therapies, a leader in the delivery of psychedelic-assisted therapy in the medical setting and the development of clinical trials, announces. 18 déc. 2024 · Rockville, Maryland, December 18, 2024 – Sunstone Therapies, a leader in the delivery of psychedelic-assisted therapy in the medical setting and the development and execution of clinical. 11 mai 2024 · Follow. Sunstone Therapies to present data on the long-term efficacy of psilocybin therapy in cancer patients with major depressive disorder (MDD) at the ASCO 2024 Annual Meeting. 11 mai 2024 · Rockville, Maryland, May 11, 2024 – Sunstone Therapies, a leader in the development of clinical trials and the delivery of psychedelic-assisted therapy in the medical setting, today announces that it will present data from the long-term study of psilocybin therapy in cancer patients with major depressive disorder (MDD). 11 mai 2024 · Sunstone Therapies to present data on the long-term efficacy of psilocybin therapy in cancer patients with major depressive disorder (MDD) at the ASCO 2024 Annual Meeting | Morningstar. 26 mai 2024 · Sunstone Therapies presents data at ASCO showing positive long-term follow-up results from psilocybin therapy in cancer patients with major depressive disorder (MDD). 11 mai 2024 · Sunstone Therapies to present data on the long-term efficacy of psilocybin therapy in cancer patients with major depressive disorder (MDD) at the ASCO 2024 Annual Meeting Rockville, Maryland, May 11, 2024 – Sunstone Therapies, a leader in the development of clinical trials and the delivery of psychedelic-assisted therapy in the. Il y a 3 jours · Senescent cells, which accumulate in organisms over time, contribute to age-related tissue decline. Genetic ablation of senescent cells can ameliorate various age-related pathologies, including. We Analyzed Dozens of Student Loan Offers to Help Find You the Best Loan for Your Needs.. Compare 2024's 10 Best Student Loans and Apply Today. Our Reviews Trusted by 45,000,000+. Stop Paying Expensive Legal Fees. Complete All of Your Paperwork Without a Lawyer. Free Fill-In Loan Agreement Templates. Create a Personalized Legal Document in Minutes. 27 nov. 2024 · The financial reports of SUNSTONE EDUVERSITY PRIVATE LIMITED include financial history (previous 5 Years), ratio analysis, management details such as directors & key persons of the company, shareholding & group structure details, mortgages & charges on SUNSTONE EDUVERSITY PRIVATE LIMITED. 23 oct. 2024 · Sunstone Eduversity Private Limited's operating revenues range is Under INR 1 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 87.07 % over the previous year. At the same time, it's book networth has decreased by -12.23 %. Funding Sunstone has raised a total of $68.1M in funding over 6 rounds. Their latest funding was raised on Aug 19, 2024 from a Series C round. Sunstone is funded by 9 investors. Alteria Capital and Westbridge Capital are the most recent investors. Unlock for free Funding Rounds Number of Funding Rounds 6 Total Funding Amount Unlock for free. 2 sept. 2024 · Get detailed financial reports of Sunstone Learning Private Limited including EBITDA, Assets, Liabilities & more on Tofler. Sign up for detailed balance sheet of Sunstone Learning Private Limited. 14 sept. 2024 · ROCKVILLE, Md., Sept. 14, 2024 /PRNewswire/ -- Sunstone Therapies, a company dedicated to treating the psychological effects of cancer, announces today the launch of a new clinical trial to. 14 sept. 2024 · Sunstone Therapies, a company dedicated to treating the psychological effects of cancer, announces today the launch of a new clinical trial to test the safety and tolerability of MDMA-assisted therapy for patients living with treatment-resistant post-traumatic stress disorder (PTSD). 14 sept. 2024 · Sunstone Therapies, a company dedicated to treating the psychological effects of cancer, announces today the launch of a new clinical trial to test the safety and tolerability of. Sunstone Therapies Collaborates with MAPS to Conduct Clinical Trial of MDMA-Assisted Therapy for PTSD Press Release The Therapeutic Potential of Psychedelic Medicine for Aging Populations. 14 sept. 2024 · Sunstone Therapies, a company dedicated to treating the psychological effects of cancer, announces today the launch of a new clinical trial to test the Sunstone Therapies Collaborates with MAPS to Conduct Clinical Trial of MDMA-Assisted Therapy for PTSD - NXT Life Science. 19 sept. 2024 · MAPS is collaborating with Sunstone Therapies to conduct a clinical trial testing the safety and tolerability of MDMA-assisted therapy for patients with treatment-resistant post-traumatic stress disorder. Retrouvez notre sélection de livres en anglais pour apprendre ou se divertir. Petits prix sur sunstone. Livraison gratuite (voir cond). Sunstone Carbon Material's latest funding round is Series B. Who are the investors of Sunstone Carbon Material? Investors of Sunstone Carbon Material include China Orient Asset Management, JISCO and Sunstone Development. To explore Sunstone Carbon Material‘s full profile, request access. Request a free trial. Information on valuation, funding, acquisitions, investors, and executives for Sunstone Carbon Material. Use the PitchBook Platform to explore the full profile. Learn more. Sunstone Development's main competitors include Alkegen, Pilkington North America, Nanogate and Binani Industries. Compare Sunstone Development to its competitors by revenue, employee growth and other metrics at Craft. 18 juil. 2017 · $55.48M Date of IPO 7/18/2017 Market Cap 1.18B Stock Price 2.17 About Sunstone Development Provider of pre-baked carbon anodes to the aluminum industry. The company develops and offers pre-baked anode carbon products mainly in China. In addition, it exports products to the rest of the world. Headquarters Location. 13 avr. 2024 · Rockville, Maryland, April 13, 2024 – Sunstone Therapies, a leader in the development of clinical trials and the delivery of psychedelic-assisted therapy in the medical setting, today. 18 déc. 2024 · Sunstone Therapies Announces Publication of Positive Phase 2 Study Results in Cancer Phase 2 trial demonstrated the safety and efficacy of psilocybin-assisted group therapy for treatment. Sunstone Therapies Announces Publication of Positive Data on Use of Psilocybin Therapy for Patients with Cancer and Major Depression Disorder, in JAMA Oncology. Sunstone Therapies Press Release. 13 avr. 2024 · Rockville, Maryland, April 13, 2024 – Sunstone Therapies, a leader in the development of clinical trials and the delivery of psychedelic-assisted therapy in the medical setting, today announces the publication of positive phase 2 data, assessing the effect of psilocybin therapy for patients with cancer and major depression disorder. 15 mai 2024 · Sunstone Properties Trust's headquarters is located at 2820 Townsgate Road, Westlake Village. Who are Sunstone Properties Trust's competitors? Competitors of Sunstone Properties Trust include Greystar Real Estate Partners and 4 more. Sunstone Properties Trust 's top competitors include Greystar Real Estate Partners, Post Properties, and Investors Management Group. GP Greystar Real Estate Partners Unclaimed Greystar provides services in the multifamily real estate business. Its business model integrates the management, development, and investment disciplines of the multifa. 31 oct. 2024 · 2024 Location Westlake Village, United States Company Stage Series B Total Funding $31.6M Latest Funding Round $25M, Series B, Jul 01, 2016 Competitor Rank 1777 th out of 7663 competitors with a Tracxn Score of 18 /100 What is this? Acquisitions Sunstone Properties Trust has not made any acquisitions yet Investments. View Sunstone Properties Trust (http://www.sunstonept.com) location in California, United States, revenue, competitors and contact information. Find and reach Sunstone Properties Trust's employees by department, seniority, title, and much more. On this week's episode of Idea Generation, actress, entrepreneur and activist Gabrielle Union takes us on a journey from her early days as a struggling actor in Los Angeles, to becoming a. 22 févr. 2024 · Net Income: Net income was $90.8 million as compared to $33.0 million. Excluding the gains on three hotels sold during 2024 and two hotels sold during 2024, net income in 2024 would have been $67.8 million as compared to a net loss of $119.5 million in 2024. Sunstone Eduversity's main competitors include ENTRI, NYC Data Science Academy, Admissify and Cengage Group. Compare Sunstone Eduversity to its competitors by revenue, employee growth and other metrics at Craft. Overview & Products Financials People Alternatives & Competitors Sunstone 's alternatives and competitors See how Sunstone compares to similar products. Sunstone 's top competitors include ImaginXP. ImaginXP Analyst Briefing Submitted ImaginXP offers technology based educational solutions. Sunstone Eduversity's top competitors include Symbiosis Institute of Business Management, ISBR and XIME. See the full list of Sunstone Eduversity alternatives and competitive updates on Owler, the world’s largest community-based business insights platform. 16 janv. 2024 · EduVersity has 865 competitors, of which 734 are active, 37 are funded and 14 have exited. Who are the newest competitors of EduVersity ? The newest competitor s of EduVersity are Course Copilot , Taalemi Academy and Getcourse .